CARSGEN-B: Notification Letter and Reply Form to Registered Shareholders
Apr 18 05:23 ET
CARSGEN-B: Notification Letter and Reply Form to Non-registered Shareholders
Apr 18 05:16 ET
CARSGEN-B: FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING
Apr 18 05:07 ET
CARSGEN-B: NOTICE OF ANNUAL GENERAL MEETING
Apr 18 05:06 ET
CARSGEN-B: PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES, RE-ELECTION OF RETIRING DIRECTORS, RE-APPOINTMENT OF AUDITOR, PROPOSED AMENDMENTS TO THE CURRENT MEMORANDUM AND ARTICLES OF ASSOCIATION AND ADOPTION OF THE EIGHTH AMENDED AND RESTATED ME
Apr 18 05:05 ET
CARSGEN-B: Annual Report 2023
Apr 18 05:04 ET
CARSGEN-B: VOLUNTARY ANNOUNCEMENT - ORAL PRESENTATION OF RESEARCH UPDATES ON SATRICABTAGENE AUTOLEUCEL AT 2024 ASCO ANNUAL MEETING
Apr 11 06:25 ET
CARSGEN-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
Apr 8 06:53 ET
CARSGEN-B: PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND THE ADOPTION OF THE EIGHTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION
Mar 26 07:37 ET
CARSGEN-B: ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2023
Mar 26 07:32 ET
CARSGEN-B: Letter to Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications
Mar 18 04:36 ET
CARSGEN-B: Letter to Non-registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications
Mar 18 04:34 ET
CARSGEN-B: DATE OF BOARD MEETING
Mar 12 04:32 ET
CARSGEN-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
Mar 6 07:06 ET
CARSGEN-B: INSIDE INFORMATION ANNOUNCEMENT - THE NMPA APPROVES THE BCMA CAR-T THERAPY ZEVORCABTAGENE AUTOLEUCEL FOR THE TREATMENT OF ADULT PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA WHO HAVE PROGRESSED AFTER AT LEAST 3 PRIOR LINES OF THERAPY (I
Feb 29 23:26 ET
CARSGEN-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024
Feb 6 06:32 ET
CARSGEN-B: VOLUNTARY ANNOUNCEMENT - UPDATED RESEARCH RESULTS ON CT041 AT 2024 ASCO GI MEETING
Jan 18 19:00 ET
CARSGEN-B: VOLUNTARY ANNOUNCEMENT - CT011 ACHIEVED IND CLEARANCE FROM THE NMPA FOR PATIENTS WITH GPC3-POSITIVE STAGE IIIa HEPATOCELLULAR CARCINOMA AT HIGH RISK OF RECURRENCE AFTER SURGICAL RESECTION
Jan 14 19:00 ET
CARSGEN-B: CHANGE OF AUDITOR
Jan 12 09:40 ET
CARSGEN-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
Jan 5 05:46 ET
No Data
No Data